Dechra Pharmaceuticals plc (LON:DPH) has announced that after 12 years’ service with Dechra, Tony Griffin will step down as an Executive Director of the Company with immediate effect. In addition, Tony confirmed that he wishes to retire from his role as Managing Director of DVP Europe, this will be effective as at 31 December 2023.
Consequently, as he is not now seeking re-election at the 2023 Annual General Meeting, Resolution 7 contained in the Notice of Meeting, published on 14 November 2023 has been withdrawn.
Ian Page, Chief Executive Officer, Dechra Pharmaceuticals said:
“I would like to take this opportunity to thank Tony for the significant contribution that he has made to the Group during his tenure. Tony joined us following the acquisition of Eurovet in 2013. This was a transformative acquisition, providing critical mass, new markets, a wide range of complementary products and additional expertise to our management team.“
